Denali Therapeutics

-$1.15 (-4.71%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell DNLI and other ETFs, options, and stocks.

About DNLI

Denali Therapeutics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of a portfolio of product candidates for neurodegenerative diseases. Its product pipeline includes LRRK2, RIPK1, TREM2, and Tau.

CEO
Ryan J. Watts
Employees
380
Headquarters
San Francisco, California
Founded
2013

DNLI Key Statistics

Market cap
2.90B
Price-Earnings ratio
—
Dividend yield
—
Average volume
668.55K
High today
$24.10
Low today
$22.73
Open price
$24.10
Volume
454.94K
52 Week high
$79.70
52 Week low
$20.24

DNLI Earnings

-$0.69
$0.18
$1.04
$1.91
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Estimated
— per share
Actual
Expected Aug 3, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure